BMRN Stock Down on Mixed Results From Rare Disease Therapy Study
19/5 18:56
BioMarin shares fall after BMN 401 meets a biomarker goal but misses a key radiographic endpoint in a late-stage ENPP1 deficiency study....
|
|
|
19/5 18:56
BioMarin shares fall after BMN 401 meets a biomarker goal but misses a key radiographic endpoint in a late-stage ENPP1 deficiency study....